CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22,500 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06099028
NCT06099028N/ACompleted

Heart Failure Treatment Pattern Analysis of HF Patients in HF Centers and Non-HF Centers in China: a Retrospective Database-based Study

Peking University First Hospital·observational·Posted Oct 25, 2023·Updated Jan 23, 2024

In Brief

An observational study evaluating no intervention for Heart Failure. Completed, enrolled 22,500 participants across 1 site.

Detailed Summary

This is a retrospective, researcher-initiated, database-based study that will retrospectively observe the treatment and medication patterns of about 22,500 patients with heart failure from 25 heart failure centers and 25 non-heart failure centers in the database of heart failure center. The proportion of patients with heart failure treatment drugs reaching the target dose recommended in the guidelines and discontinuation rate will be observed at 1 month, 3 months and 12 months follow up time point. The purpose of this study is to illustrate the current HF treatment status in HF center hospitals and non-HF center hospitals, which may provide insights for improving the clinical practice of heart failure treatment in China, and promote the standardization of heart failure treatment in China.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesChina

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 25, 2023
Enrollment StartSep 1, 2021
Primary CompletionMar 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 2.7 years ago

Interventions

no interventionother

no intervention